Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business conference participation

Optimi Health at H.C. Wainwright Conference

Analysis based on 6 articles · First reported Sep 08, 2026 · Last updated Sep 08, 2026

Sentiment
5
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement has minimal direct market impact, as it is a routine investor-relations notice of conference participation rather than a disclosure of financial results, guidance, or clinical milestones. Any effect would be limited to incremental visibility for Optimi Health among institutional investors attending the H.C. Wainwright conference.

pharmaceuticals psychedelic therapeutics

Optimi Health announced on September 8, 2026 that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14-16, 2026 at the Lotte New York Palace Hotel in New York City. The company stated that a presentation will be available on demand beginning Friday, September 11, 2026 at 7:00 a.m. ET, and that management will be available for one-on-one meetings throughout the conference. Investors interested in scheduling a meeting were directed to contact their H.C. Wainwright representative or register for the conference. Optimi Health is a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, producing GMP-grade MDMA and botanical psilocybin at Canada — Health Canada-licensed facilities in British Columbia, Canada. Its products are prescribed to patients in Australia under the Authorized Prescriber Scheme and are accessible in Canada through the Special Access Program. The announcement is a routine investor-relations disclosure with no financial terms, guidance, or clinical data attached.

60 Optimi Health announced participation H.C. Wainwright & Co.
40 Optimi Health scheduled presentation
stock
Optimi Health is the central entity of the event, announcing its participation in the H.C. Wainwright 28th Annual Global Investment Conference and making its presentation available on demand from September 11, 2026. The event offers the company a platform to engage investors, though no financial or clinical news was disclosed.
Importance 100.0 Sentiment 5.0
priv
H.C. Wainwright & Co. is the host of the 28th Annual Global Investment Conference where Optimi Health will present and hold one-on-one meetings; the event is a routine part of its investment-banking conference calendar.
Importance 60.0 Sentiment 0.0
govactor
Canada — Health Canada is referenced as the licensing authority under which Optimi Health manufactures GMP-grade psychedelic drug products; no new regulatory action is involved in this event.
Importance 20.0 Sentiment 0.0
per
Dane Stevens is identified as CEO of Optimi Health and the investor contact for the company; he is not reported to have a specific speaking role at the conference.
Importance 20.0 Sentiment 0.0
cnt
Canada is the location of Optimi Health's GMP-compliant manufacturing facilities in British Columbia and the jurisdiction of its Special Access Program, providing context for the company's operations.
Importance 15.0 Sentiment 0.0
cnt
Australia is cited as a market where Optimi Health products are prescribed to patients under the Authorized Prescriber Scheme, illustrating the company's international reach.
Importance 15.0 Sentiment 0.0
exch
Nasdaq is the exchange where Optimi Health shares (OPTH) are listed, relevant only as the trading venue for the company's stock.
Importance 10.0 Sentiment 0.0
exch
The Canadian Securities Exchange is the exchange where Optimi Health shares (OPTI) are listed, relevant only as the trading venue for the company's stock.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.